Cardiovascular Systems, Inc. to Participate at the Raymond James Human Health Innovations Conference

Rhea-AI Summary

Cardiovascular Systems, Inc. (NASDAQ: CSII) has announced its participation in the Raymond James Human Health Innovations Conference on June 23, 2021, where management will conduct investor meetings. The event is scheduled for 10:40 a.m. ET, and a webcast will be available on CSI's website. The company specializes in innovative medical devices for treating vascular and coronary diseases, notably its orbital atherectomy system that addresses limitations in current treatment methods. For more details, visit www.csi360.com.

Cardiovascular Systems, Inc. (CSI^®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at the Raymond James Human Health Innovations Conference on June 23^rd. A webcast of the presentation will be made available on CSI's website.

Raymond James Human Health Innovations Conference
Wednesday, June 23, 2021
10:40 a.m. ET

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210602005172/en/

FAQ

When is the Raymond James Human Health Innovations Conference for CSII?

The event is scheduled for June 23, 2021, at 10:40 a.m. ET.

How can I watch CSI's presentation at the conference?

You can access the webcast on CSI's website on the day of the event.

What does Cardiovascular Systems, Inc. focus on?

The company develops innovative medical devices for treating vascular and coronary diseases.

What is the primary product of CSII mentioned in the press release?

CSII's primary product is its orbital atherectomy system for treating calcified and fibrotic plaque.

Where is Cardiovascular Systems, Inc. located?

CSI is based in St. Paul, Minnesota.